Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

The conundrum of serum ferritin measurement in patients with chronic kidney disease.

Tarng DC.

Nat Clin Pract Nephrol. 2009 Feb;5(2):66-7. doi: 10.1038/ncpneph1018. Epub 2008 Dec 9.

PMID:
19065129
2.

Variability of ferritin measurements in chronic kidney disease; implications for iron management.

Ford BA, Coyne DW, Eby CS, Scott MG.

Kidney Int. 2009 Jan;75(1):104-10. doi: 10.1038/ki.2008.526. Epub 2008 Oct 8.

3.

The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?

Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH.

Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S9-18. Review.

5.

Comparing the efficacy of intravenous iron and oral iron in nondialysis patients with chronic kidney disease.

Hörl WH.

Nat Clin Pract Nephrol. 2008 Oct;4(10):530-1. doi: 10.1038/ncpneph0913. Epub 2008 Aug 19.

PMID:
18711422
6.

Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.

Lyseng-Williamson KA, Keating GM.

Drugs. 2009;69(6):739-56. doi: 10.2165/00003495-200969060-00007. Review.

PMID:
19405553
7.

Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?

Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR.

Adv Chronic Kidney Dis. 2009 Mar;16(2):143-51. doi: 10.1053/j.ackd.2008.12.008. Review.

PMID:
19233073
8.

Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.

De Sanctis V, De Sanctis E, Ricchieri P, Gubellini E, Gilli G, Gamberini MR.

Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:174-80.

PMID:
19337174
9.

A ferritin level >50 microg/L is frequently consistent with iron deficiency.

Koulaouzidis A, Cottier R, Bhat S, Said E, Linaker BD, Saeed AA.

Eur J Intern Med. 2009 Mar;20(2):168-70. doi: 10.1016/j.ejim.2007.09.024. Epub 2008 Aug 5.

PMID:
19327606
10.

Erythropoietic agents, iron and hemoglobin--What happens beyond the trial setting: observational data from the ANZDATA registry.

McDonald SP, Marshall MR, Kerr PG, Russ GR.

Hemodial Int. 2004 Jul 1;8(3):257-64. doi: 10.1111/j.1492-7535.2004.01103.x.

PMID:
19379425
11.

Malnutrition-Inflammation Score for risk stratification of patients with CKD: is it the promised gold standard?

Rambod M, Kovesdy CP, Kalantar-Zadeh K.

Nat Clin Pract Nephrol. 2008 Jul;4(7):354-5. doi: 10.1038/ncpneph0834. Epub 2008 Jun 3.

PMID:
18523431
12.

Iron, zinc and aluminium ferritin content of hemodialysis hyperferritinemic patients: comparison with other hyperferritinemic clinical conditions and normoferritinemic blood donors.

Spada PL, Rossi C, Alimonti A, Bocca B, Ricerca BM, Bocci MG, Carvelli M, Vulpio C, Luciani G, De Sole P.

Clin Biochem. 2009 Nov;42(16-17):1654-7. doi: 10.1016/j.clinbiochem.2009.07.021. Epub 2009 Aug 3.

PMID:
19651118
13.

Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.

Falaknazi K, Bagheri N, Taziki O.

Saudi J Kidney Dis Transpl. 2009 Mar;20(2):219-22.

14.

[Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].

Li H, Wang SX.

Zhonghua Yi Xue Za Zhi. 2009 Feb 24;89(7):457-62. Chinese.

PMID:
19567093
15.

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.

Am J Kidney Dis. 2009 Jun;53(6):1024-33. doi: 10.1053/j.ajkd.2009.02.008. Epub 2009 Apr 25.

PMID:
19394732
16.

Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.

Ewers B, Riserus U, Marckmann P.

J Ren Nutr. 2009 Sep;19(5):401-11. doi: 10.1053/j.jrn.2009.04.006. Epub 2009 Jun 21.

PMID:
19541503
17.

Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients.

Ng HY, Chen HC, Pan LL, Tsai YC, Hsu KT, Liao SC, Chuang FR, Chen JB, Lee CT.

Nephron Clin Pract. 2009;111(4):c247-52. doi: 10.1159/000209151. Epub 2009 Mar 17.

PMID:
19293593
18.

Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.

Janckila AJ, Lederer ED, Price BA, Yam LT.

Clin Nephrol. 2009 Apr;71(4):387-96.

PMID:
19356371
19.

[Analysis of the causal relations between serum ferritin elevation and latent pathologic factors by structural equation modeling].

Yamanishi H, Hotta M, Hayashi S, Hidaka Y, Iwatani Y.

Rinsho Byori. 2009 Jan;57(1):17-23. Japanese.

PMID:
19227186
20.

Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.

de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW; Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group.

J Ren Nutr. 2009 Mar;19(2):127-35. doi: 10.1053/j.jrn.2008.08.003.

PMID:
19218039
Items per page

Supplemental Content

Write to the Help Desk